Related Experiment Video
Updated: Apr 1, 2026

04:01
Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma
Published on: September 15, 2023
1.7K
Transaxillary single-incision robotic neck dissection for metastatic thyroid cancer
Sang-Wook Kang1, Woong Youn Chung1
1Department of Surgery, Yonsei University College of Medicine, C.P.O. Box 8044, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, South Korea.
Gland Surgery
|October 2, 2015
Summary
This study introduces a less invasive robotic neck dissection (ND) technique. The transaxillary single-incision robotic ND offers a precise, minimally invasive approach for metastatic thyroid cancer management.
Area of Science:
- Surgical Oncology
- Minimally Invasive Surgery
- Robotic Surgery
Background:
- Neck dissection (ND) is a complex procedure in head and neck oncology.
- Traditional ND results in significant cervical scarring and post-operative discomfort.
- Endoscopic techniques for ND have faced limitations in complexity and instrumentation.
Purpose of the Study:
- To introduce a novel, less invasive robotic neck dissection (ND) procedure.
- To present the modified transaxillary single-incision robotic ND technique.
- To evaluate its feasibility for managing metastatic thyroid cancer.
Main Methods:
- Utilized surgical robotics for enhanced precision in endoscopic neck dissection.
- Modified a previously described gasless transaxillary robotic approach.
- Performed transaxillary single-incision robotic ND for metastatic thyroid cancer.
Main Results:
- Robotic ND enables complete, compartment-oriented lymph node dissection.
- The transaxillary single-incision approach offers a less invasive alternative.
- Early outcomes indicate technical feasibility and satisfactory results without fatal complications.
Conclusions:
- The transaxillary single-incision robotic ND is a feasible and less invasive option.
- Robotic surgery enhances precision for complex head and neck procedures.
- This technique holds promise for managing metastatic thyroid cancer with improved patient outcomes.

